What does LENZ Therapeutics, Inc. do?
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as…
What is LENZ Therapeutics, Inc.'s P/E and P/B ratio?
LENZ Therapeutics, Inc. has a P/E ratio of -0.8 and a P/B ratio of 0.47.
What is LENZ Therapeutics, Inc.'s debt-to-equity ratio?
LENZ Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does LENZ Therapeutics, Inc. owe compared with what it owns?
LENZ Therapeutics, Inc. owes $0.07 for every $1 it owns (balance sheet Jun 2026), which is low.
What is LENZ Therapeutics, Inc.'s Positivity rank?
LENZ Therapeutics, Inc. is ranked #1,054 of 6,775 companies globally and #186 of 4,000 in United States on PositoAI, with a Positivity Score of 23,376.
Does LENZ Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for LENZ Therapeutics, Inc..
Where can I read the latest news about LENZ Therapeutics, Inc.?
Recent headlines about LENZ Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does LENZ Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of LENZ Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.